ClinConnect ClinConnect Logo
Search / Trial NCT02264496

Prospective Randomised Trial of Exercise and / or Antioxidants in COlorectal Cancer Patients Undergoing Surgery.

Launched by HULL UNIVERSITY TEACHING HOSPITALS NHS TRUST · Oct 14, 2014

Trial Information

Current as of June 05, 2025

Completed

Keywords

Colorectal Cancer Exercise Cpex Exercise, Physical Exercise, Aerobic Surgery

ClinConnect Summary

Study Design

This will be a prospective and randomised pilot clinical trial. For purposes of pragmatism, subjects and investigators will not be blinded to treatment allocation. The study is not blinded because it is impossible to blind investigators or patients to the exercise programme.

Patients undergoing major resectional surgery for colorectal cancer will be recruited from the Academic Surgical unit (ASU), Castle Hill Hospital. In total, 60 participants will be recruited for this pilot study and randomly allocated into 2 groups as outlined below.

The study will necessitate all partic...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult patients with colorectal cancer listed for elective resection surgery who have consented to participate in the study.
  • Exclusion Criteria:
  • History of unstable angina/unstable coronary artery disease or a heart attack in the previous month
  • Any heart related disease including but not limited to aortic stenosis, pericarditis or any thromboembolic disease
  • Severe Infections and fever
  • Uncontrolled metabolic diseases
  • Uncontrolled asthma
  • Acute non-cardiopulmonary disorder that may affect exercise performance or be aggravated by exercise
  • Resting heart rate of more than 120 BPM
  • Systolic blood pressure of more than 180 mm Hg or diastolic blood pressure of more than 110 mm Hg
  • Recent cerebrovascular accident
  • Pregnancy
  • Preexisting severe physical disability
  • Age \<18 years
  • Unwilling to allow their GP to be informed of their participation in the study

About Hull University Teaching Hospitals Nhs Trust

Hull University Teaching Hospitals NHS Trust is a leading healthcare organization dedicated to delivering high-quality patient care, education, and research. Located in Hull, England, the Trust encompasses a range of hospitals and healthcare services, providing a comprehensive spectrum of clinical specialties. With a strong commitment to advancing medical science, the Trust actively sponsors and conducts clinical trials that aim to improve patient outcomes and contribute to evidence-based practice. By collaborating with academic partners and leveraging its state-of-the-art facilities, Hull University Teaching Hospitals NHS Trust fosters an innovative research environment that prioritizes patient safety and ethical standards.

Locations

Hull, East Yorkshire, United Kingdom

Patients applied

0 patients applied

Trial Officials

John Hartley, MD FRCS

Principal Investigator

Hull and East Yorkshire NHS Trust

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials